Adrianos Nezos Selected Research

Sjogren's Syndrome (Sjogren Syndrome)

2/2022	Milk Fat Globule Epidermal Growth Factor 8 (MFGE8) Gene Variants in Rheumatoid Arthritis and Sjögren's Syndrome.
2/2021	Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3): A Novel Marker for Lymphoma Development among Patients with Young Onset Sjogren's Syndrome.
1/2018	Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: Role of methylating enzymes.
10/2017	Antibodies against citrullinated alpha enolase peptides in primary Sjogren's syndrome.
12/2016	Increased frequency of the PTPN22W* variant in primary Sjogren's Syndrome: Association with low type I IFN scores.
9/2015	Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis.
6/2014	B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adrianos Nezos Research Topics

Disease

9	Lymphoma (Lymphomas) 08/2021 - 01/2015
8	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2022 - 11/2016
7	Sjogren's Syndrome (Sjogren Syndrome) 02/2022 - 06/2014
6	Rheumatoid Arthritis 06/2022 - 10/2017
6	Atherosclerosis 06/2022 - 01/2018
2	Inflammation (Inflammations) 06/2022 - 05/2021
2	B-Cell Lymphoma (Lymphoma, B Cell) 02/2021 - 01/2018
2	Fatigue 11/2019 - 01/2016
2	Autoimmune Diseases (Autoimmune Disease) 11/2016 - 11/2009
1	Atherosclerotic Plaque (Atheroma) 06/2022
1	Disease Susceptibility (Diathesis) 01/2022
1	Arthritis (Polyarthritis) 01/2022
1	Human Influenza (Influenza) 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Necrosis 01/2020
1	Aicardi-Goutieres syndrome 01/2020
1	Chilblain lupus 1 01/2020
1	Systemic Scleroderma (Systemic Sclerosis) 01/2020
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 12/2019
1	Hyperhomocysteinemia 11/2019
1	Purpura 05/2018
1	Lupus Nephritis 11/2016
1	Fibromyalgia (Fibrositis) 01/2016
1	Arthralgia (Joint Pain) 01/2016
1	Chronic Disease (Chronic Diseases) 01/2016
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2016
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2013
1	Neoplasm Metastasis (Metastasis) 09/2013
1	Circulating Neoplastic Cells 09/2013
1	Lung Neoplasms (Lung Cancer) 09/2013
1	Breast Neoplasms (Breast Cancer) 12/2012
1	Osteosarcoma (Osteogenic Sarcoma) 12/2011
1	Capsule Opacification 03/2011
1	Neoplasms (Cancer) 08/2010
1	Prostatic Neoplasms (Prostate Cancer) 08/2010

Drug/Important Bio-Agent (IBA)

6	Interferon Type IIBA 01/2021 - 01/2015
5	B-Cell Activating FactorIBA 06/2022 - 06/2014
5	Messenger RNA (mRNA)IBA 01/2021 - 09/2013
4	Sodium Glutamate (Accent)IBA 01/2021 - 09/2015
4	AntibodiesIBA 11/2019 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2015
3	Retroelements (Retrotransposon)IBA 01/2021 - 11/2016
3	InterferonsIBA 01/2020 - 09/2015
3	Proteins (Proteins, Gene)FDA Link 11/2019 - 11/2016
3	Peptides (Polypeptides)IBA 10/2017 - 08/2010
2	DNA (Deoxyribonucleic Acid)IBA 02/2022 - 08/2021
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2022 - 11/2019
2	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2021 - 11/2019
2	AutoantibodiesIBA 11/2019 - 05/2018
2	Protein Isoforms (Isoforms)IBA 12/2011 - 03/2011
1	SteroidsIBA 06/2022
1	milk fat globuleIBA 02/2022
1	Epidermal Growth Factor (EGF)IBA 02/2022
1	Anti-Citrullinated Protein AntibodiesIBA 01/2022
1	OsteoprotegerinIBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2021
1	Interleukin-6 (Interleukin 6)IBA 05/2021
1	Interleukin-8 (Interleukin 8)IBA 05/2021
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 05/2021
1	Immunoglobulins (Immunoglobulin)IBA 02/2021
1	Neutralizing AntibodiesIBA 01/2021
1	Lipoproteins (Lipoprotein)IBA 01/2021
1	COVID-19 VaccinesIBA 01/2021
1	Interferon-gamma (Interferon, gamma)IBA 01/2020
1	Exonucleases (3' 5' Exonuclease)IBA 01/2020
1	three prime repair exonuclease 1IBA 01/2020
1	Antiphospholipid AntibodiesIBA 12/2019
1	LipidsIBA 11/2019
1	Parathyroid Hormone (Parathormone)IBA 11/2019
1	Interleukin-18 (Interleukin 18)IBA 11/2019
1	flt3 ligand protein (flt3 ligand)IBA 11/2019
1	NeuropeptidesIBA 11/2019
1	interferon regulatory factor-8 (interferon consensus sequence binding protein)IBA 11/2019
1	CytokinesIBA 11/2019
1	LDL Lipoproteins (beta Lipoproteins)IBA 05/2018
1	AntigensIBA 05/2018
1	oxidized low density lipoproteinIBA 05/2018
1	Complement System Proteins (Complement)IBA 05/2018
1	Immunoglobulin M (IgM)IBA 01/2018
1	EnzymesIBA 01/2018
1	Phosphopyruvate Hydratase (Enolase)IBA 10/2017
1	ElementsIBA 11/2016
1	Nucleic AcidsIBA 11/2016
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2016
1	Biological ProductsIBA 01/2016
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2016
1	hydroxide ionIBA 01/2016
1	N 30IBA 09/2015
1	Parathyroid Hormone-Related ProteinIBA 09/2013
1	Hormones (Hormone)IBA 12/2012
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2010
1	CD40 Ligand (CD40L)IBA 11/2009

Therapy/Procedure

1	Therapeutics 01/2016